Join
Live feed
·
INSIDERFilingvia Quantisnow
Ionis Pharmaceuticals Inc. logo

EVP, Chief Business Officer Baroldi Joseph was granted 10,278 shares and sold $439,364 worth of shares (5,296 units at $82.96), increasing direct ownership by 12% to 45,413 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.